In an interview with Pharmacy Times, Ming-Hei Tai, PharmD, BCOP, discusses whether durvalumab plus BCG offers enough clinical benefit to change practice in high-risk non–muscle-invasive bladder cancer.

Angie Maynard, PharmD discusses RCC immunotherapy guidelines, treatment selection, toxicity management, and pharmacists’ clinical role.

Modern pharmacists increasingly serve as translators, helping patients navigate health care complexity, reduce confusion, and improve understanding through meaningful conversations.

FDA advisory vote boosts access hopes for peptide supporters, but compounding stays illegal pending rulemaking.

Preclinical data show a GLP-1 receptor agonist reprogrammed lung macrophages and prevented post-COVID pulmonary fibrosis in diabetic mice.

FDA clears ensitrelvir oral postexposure pill to prevent symptomatic COVID-19 after close contact, cutting infections in household trial with comparable safety.